|
1
|
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
|
J Clin Oncol
|
1999
|
12.42
|
|
2
|
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
|
Ann Oncol
|
1999
|
2.84
|
|
3
|
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
|
Ann Oncol
|
2000
|
2.66
|
|
4
|
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
|
Histopathology
|
2000
|
2.51
|
|
5
|
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997.
|
Hematol J
|
2000
|
2.34
|
|
6
|
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
|
Mod Pathol
|
2000
|
1.68
|
|
7
|
Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin.
|
Blood
|
1993
|
1.49
|
|
8
|
Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia.
|
Int J Cancer
|
1977
|
1.31
|
|
9
|
MPN-associated myelofibrosis (MPN-MF).
|
Leuk Res
|
2010
|
1.25
|
|
10
|
Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model.
|
Br J Haematol
|
1997
|
1.22
|
|
11
|
Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: evidence for in vivo synergy.
|
Blood
|
1996
|
1.16
|
|
12
|
Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
|
Genes Chromosomes Cancer
|
1998
|
1.02
|
|
13
|
Acute panmyelosis with myelofibrosis: a clinicopathological study on 46 patients including histochemistry of bone marrow biopsies and follow-up.
|
Ann Hematol
|
2004
|
1.00
|
|
14
|
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations.
|
Blood
|
1977
|
0.98
|
|
15
|
Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia?
|
Arch Intern Med
|
1976
|
0.94
|
|
16
|
Disseminated atypical mycobacterial infection in patients with hairy cell leukemia.
|
Am J Med
|
1986
|
0.93
|
|
17
|
Multiple hemopoietic lineages are found after stimulation of mouse bone marrow precursor cells with interleukin 3.
|
Am J Pathol
|
1984
|
0.90
|
|
18
|
Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes.
|
Blood
|
1976
|
0.90
|
|
19
|
Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia.
|
Am J Hematol
|
1982
|
0.87
|
|
20
|
Differential counts and survival in lung cancer.
|
Lancet
|
1978
|
0.85
|
|
21
|
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
|
J Clin Oncol
|
1986
|
0.84
|
|
22
|
Prognostic significance of immunological tests in lung cancer.
|
Clin Exp Immunol
|
1981
|
0.82
|
|
23
|
Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics.
|
Br J Haematol
|
1978
|
0.82
|
|
24
|
Haematopoietic malignancies in zoo animals.
|
J Comp Pathol
|
1992
|
0.81
|
|
25
|
Fourth International Workshop on Chromosomes in Leukemia 1982: Correlation between morphology and karyotype.
|
Cancer Genet Cytogenet
|
1984
|
0.81
|
|
26
|
Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia.
|
Cancer
|
1979
|
0.80
|
|
27
|
Acute leukemia after treatment of lymphoma.
|
N Engl J Med
|
1977
|
0.80
|
|
28
|
HTLV-I sequence in lymphoproliferative disorders.
|
Diagn Mol Pathol
|
1993
|
0.79
|
|
29
|
Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
|
Best Pract Res Clin Haematol
|
2006
|
0.79
|
|
30
|
Hairy cell leukemia: diagnosis and management.
|
CA Cancer J Clin
|
1978
|
0.78
|
|
31
|
Extramedullary hematopoiesis.
|
Arch Dermatol
|
1984
|
0.77
|
|
32
|
Histiocytic lymphoma: response to chemotherapy.
|
Ann Intern Med
|
1982
|
0.75
|
|
33
|
Recurring diagnostic problems in the pathology of the myelodysplastic syndromes.
|
Semin Hematol
|
1996
|
0.75
|
|
34
|
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist?
|
Blood
|
1985
|
0.75
|
|
35
|
Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia.
|
Cancer Genet Cytogenet
|
1982
|
0.75
|
|
36
|
Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations.
|
Br J Haematol
|
1979
|
0.75
|
|
37
|
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia.
|
Cancer
|
1980
|
0.75
|
|
38
|
The zeta sedimentation ratio in children.
|
J Pediatr
|
1984
|
0.75
|